Physician profile
Jonathan D Dee
NPI 1346335957
$880.07
in general payments reported to CMS, 2019-2025
20 companies · $51.55 in 2025
The $51.55 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.36 · 2020: $15.47 · 2021: $109 · 2022: $234 · 2023: $284 · 2024: $153 · 2025: $51.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $308.16 | 2022-2024 | Freestyle Libre 3 |
| Abbvie INC. | $115.51 | 2022-2023 | Vraylar |
| Novo Nordisk INC | $91.64 | 2021-2024 | Wegovy |
| Heartflow, INC. | $51.55 | 2025 | |
| Daiichi Sankyo INC. | $51.48 | 2022-2023 | Injectafer |
| Amgen INC. | $27.73 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.18 | 2019 | |
| Dexcom, INC. | $20.61 | 2024 | Dexcom G6 Transmitter |
| Philips North America LLC | $19.35 | 2024 | (Ck7) Extended Holter |
| Novartis Pharmaceuticals Corporation | $18.65 | 2023 | |
| Astellas Pharma US INC | $18.28 | 2023 | Myrbetriq |
| Teva Pharmaceuticals USA, INC. | $17.84 | 2021 | |
| Amarin Pharma, INC. | $17.47 | 2021 | |
| Merck Sharp & Dohme LLC | $15.76 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.69 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.78 | 2021 | |
| Boston Scientific Corporation | $14.29 | 2024 | |
| Dynavax Technologies Corporation | $14.15 | 2023 | Heplisav-B |
| Eisai INC. | $13.77 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.